1. 09 Nov 2022  |  Global  |  Technology Research

    Emerging Therapeutics for Rare Neuromuscular Diseases: Pipeline Analysis

    Strategic partnering and new product development will enable better biologics for personalized and targeted treatment

    Muscle weakness, cramps, and impaired musculoskeletal functions that occur due to rare defects in nerve and muscle cells characterize neuromuscular disorders (NMDs). The disorders are largely classified as motor neuron diseases, hereditary ataxias, peripheral nerve disorders, neuromuscular junction transmission disorders, and myopathies. NMDs prese...

    $4,950.00
  2. 11 Nov 2022  |  North America  |  Market Research

    Global Contract Research Organization (CRO) Growth Opportunities

    Strong Competitive Intensity is Mandating a Greater Industry Convergence Resulting in a Strong Market Growth

    The COVID-19 pandemic led to a sudden surge in R&D activities across the world. Both small and large pharmaceutical and biotech companies were engaged in tremendous efforts to either develop new molecules or repurpose existing therapies as potential drugs for COVID-19 treatment. The trend is likely to continue with small-to-medium-segment and e...

    $4,950.00
  3. 16 Nov 2022  |  North America  |  Frost Radar

    Frost Radar™: Cell and Gene Therapy Contract Development and Manufacturing Organizations, 2022

    A Benchmarking System to Spark Companies to Action-Innovation that Fuels New Deal Flow and Growth Pipelines

    As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...

    $4,950.00
  4. 16 Nov 2022  |  North America  |  Market Research

    Cardiac Troponin Diagnostics—Forecasts and Opportunities to 2025

    Demand for High Sensitivity Point-of-Care Testing Enhance Growth Potential

    Cardiac troponin (cTn) biomarkers are the gold standard in myocardial infarction (MI) diagnosis, leading healthcare professionals to use cTn diagnostics. In addition, a rising number of patients visit emergency departments (EDs) with cardiac complaints, increasing ED demand for kits that can rapidly rule MI in or out. Both factors serve as signif...

    $4,950.00
  5. 23 Nov 2022  |  Global  |  Technology Research

    Magnetic Resonance Imaging (MRI): Technology Innovation and Growth Opportunities

    Portable MRI Systems, Emerging Metamaterials, and Artificial Intelligence will Revolutionize MRI.

    Magnetic resonance imaging (MRI) is an advanced non-invasive imaging technology that creates clear images of organs and structures inside the body. However, the claustrophobic narrow bore size design that causes patient anxiety during the scan and the stationary nature of the large machine hinder the optimal use of this technology, and low-quality ...

    $4,950.00
  6. 24 Nov 2022  |  Global  |  Technology Research

    Solid Organ Transplantation Technologies and Growth Opportunities

    Next-generation Sequencing-based Transplant Diagnostics and Normothermic Organ Perfusion Technologies Enabling Better Post-transplant Outcomes and Increases Donor Organ Availability

    The organ donation and transplant community is facing a constant scarcity of adequate donor organs to meet the unceasingly increasing demand. All innovations in the solid organ transplant industry focus on increasing the availability of donor organs and improving post-transplant outcomes post-transplant. Pre- and post-transplant diagnostics are us...

    $4,950.00
  7. 01 Dec 2022  |  North America  |  Market Research

    Global in Vitro Fertilization Services Growth Opportunities

    Disruptive Technologies and Innovative Business Models are the Key Drivers in the IVF Services Industry

    This study analyzes the in vitro fertility (IVF) services market across the globe. With infertility rates increasing across the world, assisted reproductive technologies (ART), including IVF, are gaining prominence. With technology advancements, the IVF process has undergone several modifications, with mainstream service providers such as fertility...

    $4,950.00
  8. 05 Dec 2022  |  Global  |  Market Outlook

    Outlook 2023: Top 10 Growth Opportunities for MedTech

    Growth Opportunities for the Medtech Industry

    Frost & Sullivan’s Medtech and Imaging programs explore, articulate, and address the medical industry’s most pressing questions related to growth. The programs focus on core segments such as care delivery, care management, imaging informatics, intelligent imaging, and business models. They independently review and identify companies that are pr...

    $2,450.00
  9. 07 Dec 2022  |  Global  |  Market Outlook

    Outlook 2023: Top 10 Growth Opportunities for Digital Health

    Predictions for the Digital Health Industry

    Healthcare during the COVID-19 pandemic has undeniably seen some of its most significant changes. The growth of digital health was a silver lining, and enterprise IT solution providers and telehealth vendors saw tremendous growth during this time. They will continue to see the same in the coming years. Digital health continued to have a winning str...

    $2,450.00
  10. 13 Dec 2022  |  Global  |  Technology Research

    Companion Diagnostics (CDx): Technology Innovation and Growth Opportunities

    The Transition to Precision Medicine is Propelling the Adoption of CDx Platforms.

    The concept of companion diagnostics (CDx) was developed when researchers realized that even potent drugs only had an efficacy between 25% and 60%, the lowest being in oncology. Therefore, a clinical pharmacogenetic assay became important to distinguish patients more likely to respond to a drug or at a lesser risk of associated adverse pathophysiol...

    $4,950.00